Abbott's investigational device achieved 96.3% complete left atrial appendage closure by echocardiography, with a 1.8% ischemic stroke rate at 1 year.
News|Articles|January 11, 2021
Depression Screening Tools for Primary Care
Author(s)Veronica Hackethal, MD
Prevalence of depression in the US has increased nearly 3-fold since before COVID-19. Here, a primer on the best assessment tools for depression diagnosis in primary care.
Advertisement
Primary care doctors are often the first health care provider patients see when they are dealing with symptoms of depression. Research has shown that the prevalence of depressive symptoms has increased during the coronavirus disease 2019 (COVID-19) pandemic and may be 3-times higher than before
Advertisement
Related to this article
Hormone Therapy Linked to More Frequent Migraines, but Not Greater Severity, in Postmenopausal Women
TMS 2026: A meta-analysis of 5 studies found hormone therapy linked to more frequent migraine attacks and migraine days, but not greater severity or analgesic use.
FDA has granted IDE approval for the STROKE-REWIRE pivotal trial evaluating NeuWire Medical's neurostimulation device for chronic ischemic stroke recovery.
Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
Stroke incidence in adults aged 20–54 nearly doubled from 1993–1994 to 2020, driven largely by ischemic stroke, while 30-day fatality declined, according to new research.
October FDA news included updates on long-acting olanzapine, multi-cancer blood testing, stroke rehabilitation, and heart failure monitoring.
Christoph Correll, MD, discusses the new once-monthly olanzapine injection for schizophrenia, including clinical efficacy, metabolic risks, and patient selection.
Cheryl Cox Kinney, MD, explains when night sweats warrant further evaluation, including red flags, persistent symptoms, and potential nonmenopausal causes.
Advertisement
Advertisement
Trending on Patient Care Online
1
When Night Sweats Signal Something Other Than Menopause
2
Abbott's Amulet 360 Linked to Low Stroke Risk at 1 Year in Late-Breaking Research
3
4 FDA Decisions for Primary Care to Know from October 2026
4
New Schizophrenia Treatment Addresses Long-Standing LAI Barriers
5